Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01NKW
|
|||
| Former ID |
DIB016381
|
|||
| Drug Name |
P2B-001
|
|||
| Synonyms |
Fixed-dose combination therapy (Parkinsons diease), Pharma Two B
Click to Show/Hide
|
|||
| Indication | Parkinson disease [ICD-11: 8A00.0; ICD-9: 332] | Phase 3 | [1] | |
| Company |
Pharma Two B Ltd
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | Pharmacology of pramipexole, a dopamine D3-preferring agonist useful in treating Parkinson's disease. Clin Neuropharmacol. 1998 May-Jun;21(3):141-51. | |||
| REF 3 | Rasagiline (TVP-1012): a new selective monoamine oxidase inhibitor for Parkinson's disease. Am J Geriatr Pharmacother. 2006 Dec;4(4):330-46. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.